EUVIMEDSkopri EUVIMED
Crossref

Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease

Federica Tavaglione iD, Valentina Flagiello, Francesca Terracciani, Paolo Gallo, Emma Capparelli, Chiara Spiezia, Antonio De Vincentis, Andrea Palermo iD, Sara Scriccia, Giovanni Galati, Nicola Napoli, Samuel J Daniels and 6 more

Diabetes/Metabolism Research and Reviews · 2024

DOI: 10.1002/dmrr.3787 ↗

At a glance

Journal article in Diabetes/Metabolism Research and Reviews, 2024. Written by Federica Tavaglione and 17 co-authors. Institution: Research Unit of Clinical Medicine and Hepatology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy. Major MEDLINE topics: Diabetes Mellitus, Type 2, Fatty Liver, Metabolic Diseases, Non-alcoholic Fatty Liver Disease. Cited 25 times so far (Crossref); 37 references. Funded by: Ricerca Finalizzata Ministero della Salute, AstraZeneca Agreement for Research, Progetti di Ricerca di Rilevante Interesse Nazionale Ministero dell'Università e della Ricerca.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Aims

Given the increasing number of individuals developing metabolic dysfunction‐associated steatotic liver disease (MASLD) and the low rate of those with progressive liver disease, there is a pressing need to conceive affordable biomarkers to assess MASLD in general population settings. Herein, we aimed to investigate the performance of the ultrasound‐derived fat fraction (UDFF) for hepatic steatosis in high‐risk individuals.

Methods

A total of 302 Europeans with obesity, type 2 diabetes, or a clinical history of hepatic steatosis were included in the analyses. Clinical, laboratory, and imaging data were collected using standardized procedures during a single screening visit in Rome, Italy. Hepatic steatosis was defined by controlled attenuation parameter (CAP) or ultrasound‐based Hamaguchi's score. UDFF performance for hepatic steatosis was estimated by the area under the receiver operating characteristic curve (AUC).

Results

Overall, median (IQR) UDFF was 12% (7–20). UDFF was positively correlated with CAP ( ρ = 0.73, p < 0.0001) and Hamaguchi's score ( ρ = 0.79, p < 0.0001). Independent predictors of UDFF were circulating triglycerides, alanine aminotransferase (ALT), and ultrasound‐measured visceral adipose tissue (VAT). UDFF AUC was 0.89 (0.85–0.93) and 0.92 (0.88–0.95) for CAP‐ and ultrasound‐diagnosed hepatic steatosis, respectively. UDFF AUC for hepatic steatosis was higher than those of fatty liver index (FLI), hepatic steatosis index (HSI), CAP‐score (CAPS), and ALT ( p < 0.0001). Lower age, ALT, and VAT were associated with discordance between UDFF and ultrasound.

Conclusions

UDFF may be a simple and accurate imaging biomarker to assess hepatic steatosis and monitor changes in hepatic fat content over time or in response to therapeutic interventions beyond clinical trials.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Fatty LiverMetabolic DiseasesNon-alcoholic Fatty Liver DiseaseHumansLiverUltrasonographyROC CurveBiomarkers

Author keywords

NAFLDNASHabdominal ultrasoundcontrolled attenuation parameterfatty liverimaging biomarkers

Substances

Biomarkers

Authors and institutions

  • Research Unit of Clinical Medicine and Hepatology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Operative Unit of Clinical Medicine and Hepatology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Research Unit of Food Science and Human Nutrition, Department of Science and Technology for Sustainable Development and One Health, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Research Unit of Internal Medicine, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
  • Operative Unit of Internal Medicine, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.
  • Research Unit of Metabolic Bone and Thyroid Disorders, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.

ORCID profiles: Federica Tavaglione, Andrea Palermo, Umberto Vespasiani-Gentilucci

Funding

  • Ricerca Finalizzata Ministero della Salute
  • AstraZeneca Agreement for Research
  • Progetti di Ricerca di Rilevante Interesse Nazionale Ministero dell'Università e della Ricerca
  • Ministero della Salute
  • Ministero dell'Università e della Ricerca

Cite

APA

Tavaglione, F., Flagiello, V., Terracciani, F., Gallo, P., Capparelli, E., Spiezia, C., De Vincentis, A., Palermo, A., Scriccia, S., Galati, G., Napoli, N., Daniels, S. J., Blau, J. E., Carlsson, B., Khazrai, Y. M., Incalzi, R. A., Picardi, A., & Vespasiani-Gentilucci, U. (2024). Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease. Diabetes/Metabolism Research and Reviews. https://doi.org/10.1002/dmrr.3787

Vancouver

Tavaglione F, Flagiello V, Terracciani F, Gallo P, Capparelli E, Spiezia C, et al. Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease. Diabetes/Metabolism Research and Reviews. 2024. doi:10.1002/dmrr.3787

BibTeX
@article{Tavaglione2024,
  author = {Tavaglione, Federica and Flagiello, Valentina and Terracciani, Francesca and Gallo, Paolo and Capparelli, Emma and Spiezia, Chiara and De Vincentis, Antonio and Palermo, Andrea and Scriccia, Sara and Galati, Giovanni and Napoli, Nicola and Daniels, Samuel J and Blau, Jenny E and Carlsson, Björn and Khazrai, Yeganeh M and Incalzi, Raffaele Antonelli and Picardi, Antonio and Vespasiani-Gentilucci, Umberto},
  title = {Non‐invasive assessment of hepatic steatosis by ultrasound‐derived fat fraction in individuals at high‐risk for metabolic dysfunction‐associated steatotic liver disease},
  journal = {Diabetes/Metabolism Research and Reviews},
  year = {2024},
  doi = {10.1002/dmrr.3787}
}
Start for free →